X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (573) 573
wet macular degeneration - physiopathology (539) 539
index medicus (538) 538
ophthalmology (482) 482
male (481) 481
female (480) 480
aged (469) 469
wet macular degeneration - drug therapy (456) 456
intravitreal injections (392) 392
visual acuity - physiology (381) 381
aged, 80 and over (373) 373
ranibizumab (348) 348
vascular endothelial growth factor a - antagonists & inhibitors (339) 339
tomography, optical coherence (331) 331
macular degeneration (323) 323
angiogenesis inhibitors - therapeutic use (316) 316
middle aged (254) 254
wet macular degeneration - diagnosis (243) 243
fluorescein angiography (222) 222
treatment outcome (222) 222
bevacizumab (215) 215
retrospective studies (201) 201
physiological aspects (176) 176
age-related macular degeneration (164) 164
antibodies, monoclonal, humanized - therapeutic use (157) 157
follow-up studies (157) 157
prospective studies (154) 154
angiogenesis inhibitors - administration & dosage (132) 132
vascular endothelial growth factor (118) 118
visual acuity (110) 110
choroidal neovascularization (109) 109
ranibizumab - therapeutic use (94) 94
optical coherence tomography (87) 87
retina - pathology (80) 80
endothelial growth-factor (79) 79
therapy (79) 79
age (77) 77
care and treatment (76) 76
photodynamic therapy (76) 76
antibodies, monoclonal, humanized - administration & dosage (75) 75
retreatment (72) 72
recombinant fusion proteins - therapeutic use (69) 69
analysis (68) 68
choroidal neovascularization - physiopathology (67) 67
receptors, vascular endothelial growth factor - therapeutic use (66) 66
verteporfin (65) 65
diabetic retinopathy (61) 61
eye (61) 61
abridged index medicus (59) 59
angiogenesis inhibitors - adverse effects (59) 59
genetic structures (59) 59
time factors (59) 59
eye diseases (58) 58
choroidal neovascularization - drug therapy (56) 56
neovascularization (56) 56
degeneration (51) 51
drug therapy (51) 51
medicine & public health (49) 49
retina (49) 49
aflibercept (48) 48
visual acuity - drug effects (47) 47
ranibizumab - administration & dosage (46) 46
risk factors (46) 46
intravitreal ranibizumab (44) 44
visual-acuity (43) 43
choroidal neovascularization - diagnosis (40) 40
medical imaging (40) 40
patients (40) 40
combined modality therapy (39) 39
eyes (39) 39
prevalence (39) 39
safety (39) 39
acuity (38) 38
bevacizumab - therapeutic use (38) 38
injection (37) 37
neovascular age-related macular degeneration (37) 37
photochemotherapy (37) 37
subretinal fluid (37) 37
endothelial growth factors (36) 36
sense organs (36) 36
trial (36) 36
antibodies, monoclonal, humanized - adverse effects (35) 35
maculopathy (35) 35
disease (34) 34
surgery (34) 34
wet macular degeneration - complications (34) 34
intravitreal bevacizumab (33) 33
amd (32) 32
double-blind method (32) 32
studies (32) 32
anti-vegf (31) 31
clinical trials (31) 31
outcomes (31) 31
polypoidal choroidal vasculopathy (31) 31
prognosis (31) 31
exudates and transudates (30) 30
recombinant fusion proteins - administration & dosage (30) 30
vegf (30) 30
receptors, vascular endothelial growth factor - administration & dosage (29) 29
age‐related macular degeneration (28) 28
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (560) 560
Russian (4) 4
French (3) 3
German (3) 3
Hungarian (2) 2
Czech (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Ophthalmology, ISSN 0161-6420, 2012, Volume 119, Issue 12, pp. 2537 - 2548
Journal Article
Ophthalmology, ISSN 0161-6420, 2017, Volume 124, Issue 12, pp. 1753 - 1763
Journal Article
Journal Article
Journal Article
Journal Article